Back to today’s briefing

Story perspectives

FDA Chief Ousted Amid Gene Therapy Controversy

6/21/2025

46 6

Summary

Story summary

The FDA has parted ways with Nicole Verdun, its chief gene therapy regulator, after a clash over a Duchenne muscular dystrophy treatment review. This shake-up sparks worries about political pressures within the agency. Meanwhile, the podcast "The Readout LOUD" delves into the approval of a groundbreaking HIV prevention drug and changes in academic research funding.

1 of 1

Story summary

The FDA has parted ways with Nicole Verdun, its chief gene therapy regulator, after a clash over a Duchenne muscular dystrophy treatment review. This shake-up sparks worries about political pressures within the agency. Meanwhile, the podcast "The Readout LOUD" delves into the approval of a groundbreaking HIV prevention drug and changes in academic research funding.